Phibro Animal Health | PAHC - 应收帐款人

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.42B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	应收帐款人	更改		日
Align Technology	USD 1.15B		23.28M	2026-06
ANI Pharmaceuticals	USD 274.47M		19.04M	2026-06
Aurora Cannabis	CAD 44.58M		3.68M	2026-03
Bristol-Myers Squibb	USD 13.83B		535M	2026-06
Canopy Growth	CAD 36.29M		104.13M	2026-03
Corcept Therapeutics	USD 76.92M		37.85M	2026-06
Eli Lilly	USD 23.48B		2.3B	2026-06
Henry Schein	USD 1.76B		44M	2026-06
Idexx Laboratories	USD 627.08M		70.13M	2026-06
Knight Therapeutics	CAD 183M		7.46M	2025-12
Merck	USD 12.21B		435M	2026-03
Nektar Therapeutics	USD 3.6M		1.82M	2026-03
Pacira	USD 132.42M		6.78M	2026-06
Phibro Animal Health	USD 215.87M		2.02M	2025-12
Prestige Brands	USD 187.36M		4.56M	2026-06
Supernus Pharmaceuticals	USD 211.66M		29.47M	2026-06
Zoetis	USD 1.57B		65M	2026-06